Peers, C and Boyle, JP (2015) Oxidative Modulation of K+ Channels in the Central Nervous System in Neurodegenerative Diseases and Aging. Antioxidants & Redox Signaling, 22 (6). pp. 505-521. ISSN 1523-0864
Abstract
Significance: Oxidative stress and damage are well-established components of neurodegenerative diseases, contributing to neuronal death during disease progression. Here, we consider key K+ channels as target proteins that can undergo oxidative modulation, describe what is understood about how this influences disease progression, and consider regulation of these channels by gasotransmitters as a means of cellular protection. Recent Advances: Oxidative regulation of the delayed rectifier Kv2.1 and the Ca2+- and voltage-sensitive BK channel are established, but recent studies contest how their redox sensitivity contributes to altered excitability, progression of neurodegenerative diseases, and healthy aging. Critical Issues: Both Kv2.1 and BK channels have recently been established as target proteins for regulation by the gasotransmitters carbon monoxide and hydrogen sulfide. Establishing the molecular basis of such regulation, and exactly how this influences excitability and vulnerability to apoptotic cell death will determine whether such regulation can be exploited for therapeutic benefit. Future Directions: Developing a more comprehensive picture of the oxidative modulation of K+ channels (and, indeed, other ion channels) within the central nervous system in health and disease will enable us to better understand processes associated with healthy aging as well as distinct processes underlying progression of neurodegenerative diseases. Advances in the growing understanding of how gasotransmitters can regulate ion channels, including redox-sensitive K+ channels, are a research priority for this field, and will establish their usefulness in design of future approaches for the treatment of such diseases.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | (c) 2014, Mary Ann Liebert, Inc. Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/ars.2014.6007. Reproduced in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Genetics, Health and Therapeutics (LIGHT) > Academic Unit of Cardiovascular Medicine (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 10 May 2016 13:25 |
Last Modified: | 15 Nov 2016 22:20 |
Published Version: | http://dx.doi.org/10.1089/ars.2014.6007 |
Status: | Published |
Publisher: | Mary Ann Liebert |
Identification Number: | 10.1089/ars.2014.6007 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:98726 |